• Thurs news: Moderna posts surprise profit. How Trump victory will affect FTC, FDA. Gilead CAR-T sales stagnate. Sarepta pulls plug on Duchenne candidate. AZ China chief in custody. See more on our front page

Biohaven Pharmaceuticals

















Oh Come ON.....You really think HHS -OIG cares

Usually not, but after the dashian warning, everything is under scrutiny. Better watch out with speaker programs, especially q & a. Speakers are an agent of us, so the company takes the fall if they yap about future indications. Never f with the Feds, whether it's the IRS or FDA.
 




Usually not, but after the dashian warning, everything is under scrutiny. Better watch out with speaker programs, especially q & a. Speakers are an agent of us, so the company takes the fall if they yap about future indications. Never f with the Feds, whether it's the IRS or FDA.
My speaker loves to just let it roll. Hoping that’s not a problem!!
 
































Word on the street is more jumping ship. Not enough money to keep paying everyone for giving a drug away. Your spokesperson is laughable and I know of at least half a dozen reps who’s names were turned selling something not FDA approved. It’s going to catch up and the rest of us can’t wait.